• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗相关性认知功能障碍。

Chemotherapy-related cognitive dysfunction.

机构信息

Department of Neuro-Oncology, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 431, Houston, TX 77030, USA.

出版信息

Curr Neurol Neurosci Rep. 2012 Jun;12(3):267-75. doi: 10.1007/s11910-012-0264-9.

DOI:10.1007/s11910-012-0264-9
PMID:22453825
Abstract

Many cancer patients develop treatment-related cognitive dysfunction that affects their quality of life and can result in diminished functional independence. There is an emerging body of transdisciplinary research demonstrating that chemotherapeutic agents can produce neurobiological changes within the brain, which are associated with a constellation of cognitive changes that can result in decreased quality of life and functional independence. The increased incidence of cancer, coupled with longer survival times, has resulted in larger numbers of cancer survivors who are struggling with this neurotoxicity. This review summarizes the neuropsychological findings in patients with breast and brain cancer who receive systemic chemotherapy as well as the recent animal and imaging research elucidating the mechanisms by which these therapies impact brain structure, function, and consequent behavior.

摘要

许多癌症患者会出现与治疗相关的认知功能障碍,这会影响他们的生活质量,并导致其功能独立性下降。越来越多的跨学科研究表明,化疗药物会在大脑内引起神经生物学变化,这些变化与一系列认知变化相关,从而导致生活质量和功能独立性下降。癌症发病率的增加,加上生存时间的延长,导致越来越多的癌症幸存者正在与这种神经毒性作斗争。这篇综述总结了接受全身化疗的乳腺癌和脑癌患者的神经心理学发现,以及最近的动物和影像学研究阐明了这些治疗方法影响大脑结构、功能和随后行为的机制。

相似文献

1
Chemotherapy-related cognitive dysfunction.化疗相关性认知功能障碍。
Curr Neurol Neurosci Rep. 2012 Jun;12(3):267-75. doi: 10.1007/s11910-012-0264-9.
2
The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research.辅助治疗对乳腺癌认知功能的影响:当前证据及研究方向
Semin Oncol. 2003 Dec;30(6):749-62. doi: 10.1053/j.seminoncol.2003.09.008.
3
Brain vulnerability to chemotherapy toxicities.脑对化疗毒性的易损性。
Psychooncology. 2012 Nov;21(11):1141-8. doi: 10.1002/pon.3196. Epub 2012 Oct 1.
4
A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.一项关于用于检测乳腺癌患者化疗引起的认知障碍的各种神经心理学测试敏感性的荟萃分析。
Oncol Nurs Forum. 2007 Sep;34(5):997-1005. doi: 10.1188/07.ONF.997-1005.
5
Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.乳腺癌患者的辅助化疗与认知功能障碍
J Support Oncol. 2006 Feb;4(2):66-7.
6
Neurocognitive changes in cancer survivors.癌症幸存者的神经认知变化。
Cancer J. 2008 Nov-Dec;14(6):396-400. doi: 10.1097/PPO.0b013e31818d8769.
7
Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy.同卵双胞胎的脑结构和功能差异:乳腺癌化疗的可能影响。
J Clin Oncol. 2007 Sep 1;25(25):3866-70. doi: 10.1200/JCO.2007.10.8639.
8
Chemotherapy-related cognitive dysfunction: current animal studies and future directions.化疗相关性认知功能障碍:当前的动物研究与未来方向。
Brain Imaging Behav. 2013 Dec;7(4):453-9. doi: 10.1007/s11682-013-9250-3.
9
An update on cancer- and chemotherapy-related cognitive dysfunction: current status.癌症及化疗相关认知功能障碍的最新进展:现状。
Semin Oncol. 2011 Jun;38(3):431-8. doi: 10.1053/j.seminoncol.2011.03.014.
10
Chemotherapy, neurotoxicity, and cognitive changes in breast cancer.乳腺癌中的化疗、神经毒性和认知变化
J Cancer Res Ther. 2011 Jul-Sep;7(3):264-9. doi: 10.4103/0973-1482.87008.

引用本文的文献

1
Therapeutic potential of yoga nidra for chemo brain: a complementary and integrative perspective.瑜伽休息术对化疗脑的治疗潜力:一种补充与整合的视角
Psychoradiology. 2025 Jul 28;5:kkaf020. doi: 10.1093/psyrad/kkaf020. eCollection 2025.
2
A Cognitive Training Programme on Cancer-Related Cognitive Impairment (CRCI) in Breast Cancer Patients Undergoing Active Treatment: A RCT Study Protocol.一项针对正在接受积极治疗的乳腺癌患者的癌症相关认知障碍(CRCI)的认知训练计划:一项随机对照试验研究方案。
J Clin Med. 2025 Jul 16;14(14):5047. doi: 10.3390/jcm14145047.
3
Chemotherapy treatment alters DNA methylation patterns in the prefrontal cortex of female rat brain.

本文引用的文献

1
Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.乳腺癌辅助化疗 20 多年后幸存者的神经心理学表现。
J Clin Oncol. 2012 Apr 1;30(10):1080-6. doi: 10.1200/JCO.2011.37.0189. Epub 2012 Feb 27.
2
Fluoxetine counteracts the cognitive and cellular effects of 5-fluorouracil in the rat hippocampus by a mechanism of prevention rather than recovery.氟西汀通过预防而不是恢复的机制来抵消氟尿嘧啶在大鼠海马中的认知和细胞效应。
PLoS One. 2012;7(1):e30010. doi: 10.1371/journal.pone.0030010. Epub 2012 Jan 17.
3
Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study.
化疗会改变雌性大鼠大脑前额叶皮质中的DNA甲基化模式。
Sci Rep. 2025 Jul 1;15(1):20681. doi: 10.1038/s41598-025-07419-2.
4
Targeted activation of Nrf2 at sites of oxidative stress reverses doxorubicin-induced cognitive impairments in mice.在氧化应激位点靶向激活Nrf2可逆转阿霉素诱导的小鼠认知障碍。
Brain Behav Immun. 2025 Jun 29;129:547-556. doi: 10.1016/j.bbi.2025.06.037.
5
Donepezil for cancer-related cognitive impairment: systematic review and meta-analysis.多奈哌齐用于癌症相关认知障碍:系统评价与荟萃分析
Clin Exp Med. 2025 Jun 10;25(1):196. doi: 10.1007/s10238-025-01708-w.
6
Chronic Neurological Complications of Brain Tumors and Brain Tumor Treatments.脑肿瘤及脑肿瘤治疗的慢性神经并发症
Curr Neurol Neurosci Rep. 2025 Mar 21;25(1):26. doi: 10.1007/s11910-025-01411-z.
7
Brain tumors and fitness to drive: A review and multi-disciplinary approach.脑肿瘤与驾驶适宜性:综述与多学科方法
Neurooncol Pract. 2024 Dec 6;12(2):183-196. doi: 10.1093/nop/npae119. eCollection 2025 Apr.
8
Screening for cognitive impairment in routine clinical oncology practice: a pilot study using patient-reported outcome measures and online cognitive testing in melanoma and breast cancer patients.在常规临床肿瘤学实践中筛查认知障碍:一项在黑色素瘤和乳腺癌患者中使用患者报告结局测量和在线认知测试的试点研究。
Support Care Cancer. 2025 Mar 12;33(4):273. doi: 10.1007/s00520-025-09325-9.
9
Structural plasticity of pyramidal cell neurons measured after FLASH and conventional dose-rate irradiation.在FLASH和传统剂量率照射后测量的锥体神经元的结构可塑性。
Brain Struct Funct. 2025 Mar 1;230(2):41. doi: 10.1007/s00429-025-02902-y.
10
Microglia-Mediated Synaptic Dysfunction Contributes to Chemotherapy-Related Cognitive Impairment.小胶质细胞介导的突触功能障碍导致化疗相关的认知障碍。
J Neurochem. 2025 Mar;169(3):e70024. doi: 10.1111/jnc.70024.
接受化疗的乳腺癌女性的目标和自我报告的认知功能障碍:一项前瞻性研究。
Eur J Cancer Care (Engl). 2012 Jul;21(4):485-92. doi: 10.1111/j.1365-2354.2011.01320.x. Epub 2011 Dec 28.
4
Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.高剂量辅助化疗对乳腺癌幸存者白质和灰质的晚期影响:多模态磁共振成像的汇聚结果。
Hum Brain Mapp. 2012 Dec;33(12):2971-83. doi: 10.1002/hbm.21422. Epub 2011 Sep 23.
5
Prefrontal cortex and executive function impairments in primary breast cancer.原发性乳腺癌患者的前额叶皮质与执行功能障碍
Arch Neurol. 2011 Nov;68(11):1447-53. doi: 10.1001/archneurol.2011.245.
6
Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study.化疗前乳腺癌患者与对照组在视空间工作记忆方面的差异:一项 fMRI 研究。
Front Hum Neurosci. 2011 Nov 1;5:122. doi: 10.3389/fnhum.2011.00122. eCollection 2011.
7
Persistent cognitive deficits, induced by intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic glutamate analogs and can be reversed by an NMDA antagonist.鞘内注射甲氨蝶呤引起的持续性认知缺陷与兴奋性谷氨酸类似物的脑脊液浓度升高有关,并可被 NMDA 拮抗剂逆转。
Behav Brain Res. 2011 Dec 1;225(2):491-7. doi: 10.1016/j.bbr.2011.08.006. Epub 2011 Aug 12.
8
Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis.癌症治疗的认知副作用表明成人神经发生具有功能作用。
Behav Brain Res. 2012 Feb 14;227(2):376-9. doi: 10.1016/j.bbr.2011.05.012. Epub 2011 May 23.
9
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.复发性胶质母细胞瘤患者接受贝伐珠单抗治疗后的神经认知功能。
Neuro Oncol. 2011 Jun;13(6):660-8. doi: 10.1093/neuonc/nor024. Epub 2011 May 9.
10
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.神经肿瘤学中的反应评估( RANO 小组的报告):弥漫性低级别胶质瘤试验的结果评估。
Lancet Oncol. 2011 Jun;12(6):583-93. doi: 10.1016/S1470-2045(11)70057-2. Epub 2011 Apr 5.